Data extraction The generic and brand names of GLP-1 RAs approved by the FDA were used to identify adverse events of GLP-1 RAs in the DRUG files, including exenatide (BYETTA, BYDUREON), liraglutide (VICTOZA, SAXENDA), dulaglutide (TRULICITY), lixisenatide (ADLYXIN, SOLIQUA), and semaglutide (OZEMPIC, RYBELSUS, WEGOVY)
The world of weight loss medications has grown rapidly in recent years, especially with the introduction of GLP-1 receptor agonists
While weight loss is technically achieved through expending more energy than you take in, eating too few calories for too long can actually slow down your metabolism over time
Unknown Cancer Risks: Modulating the immune system could potentially affect cancer surveillance mechanisms
10.1016/j.lfs.2007.02.003 50 LeeJ